Biomed Middle East | Repros to meet FDA to discuss testosterone drug trial Reuters 8 to review the efficacy protocols of the late-stage trials of Androxal, its experimental drug to treat testosterone deficiency in men. ... FDA grants Type B meeting to review Phase III pivotal efficacy protocols for ... |
Thursday, September 30, 2010
Repros to meet FDA to discuss testosterone drug trial - Reuters
http://interiorartss.com/roccoco-interiors.html
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment